Potential Trimethylamine (TMA)-Producing Bacteria in patients with chronic kidney disease undergoing hemodialysis
International Urology and Nephrology · 2024
DOI: 10.1007/s11255-024-04191-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Livia Alvarenga und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil. liviaalvarenga92@gmail.com. Hauptthemen laut MEDLINE: Methylamines, Renal Dialysis, Renal Insufficiency, Chronic, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Trimethylamine (TMA), produced by gut microbiota, is the precursor of trimethylamine-N-oxide (TMAO), a uremic toxin that accumulates in patients with chronic kidney disease (CKD). Elevated TMAO plasma levels are associated with cardiovascular complications and CKD progression. OBJECTIVE: To evaluate the association between gut microbiota composition and TMAO plasma levels in CKD patients undergoing hemodialysis (HD). METHODS: This is a cross-sectional study with 25 patients evaluated (60% female, 53 (18) years, body mass index (BMI) 25.8 (6.75) Kg/m2). They were divided into two groups according to their TMAO plasma levels: normal (≤ 7.4 μM) and high (> 7.4 μM). Uremic toxins such as indoxyl sulfate (IS), p-cresyl sulfate (pCS), and indol acetic acid (IAA) were measured with RP-HPLC, and TMAO plasma levels were quantified using LC-MS/MS. Fecal DNA was extracted with a commercial kit, PCR amplified the V4 region of the 16S rRNA gene, and short-read sequencing was performed on the Illumina platform. Dietary intake, anthropometric measurements, and inflammation markers were also evaluated. Nrf2, NF-κB, IL-1β, and NLRP3 mRNA expressions were measured from peripheral blood mononuclear cells (PBMC) using quantitative real-time polymerase chain reaction (qPCR). RESULTS: There were significant positive correlations between TMAO and plasma levels of pCS, NLPR3 inflammasome mRNA expression, serum phosphorus levels, and negative correlations with dietary lipid intake. The group with TMAO > 7.4 μM showed an increase in the microbiome abundance of Saccharibacteria (genus incertae sedis), Colidextribacter, Dorea, and Staphylococci genera, and a decrease in abundance in the genera Lachnospira, Lactobacilli, and Victivallis. TMAO plasma level was positively correlated with the abundance of bacteria of the genera Colidextribacter and Helicobacter and was negatively correlated with Sphingomanos, Lachnospira, Streptomyces, and Bacillus genera. CONCLUSION: Saccharibacteria (genus incertae sedis), Colidextribacter, Dorea, and Staphylococci genera showed higher abundance in patients with high TMAO levels. In addition, we observed that elevated plasma TMAO levels are associated with inflammation markers, dietary lipid intake, and serum phosphorus levels in patients undergoing HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil. liviaalvarenga92@gmail.com.
- Graduate Program in Biological Sciences-Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. liviaalvarenga92@gmail.com.
- Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
- Graduate Program in Biological Sciences-Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Biological and Environmental Science and Engineering (BESE), Division, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Makkah, Saudi Arabia.
- Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
Zitieren
APA
Alvarenga, L., Kemp, J. A., Schultz, J., Cardozo, L. F. M. F., Nakao, L. S., Ribeiro-Alves, M., Rosado, A., & Mafra, D. (2024). Potential Trimethylamine (TMA)-Producing Bacteria in patients with chronic kidney disease undergoing hemodialysis. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04191-6
Vancouver
Alvarenga L, Kemp JA, Schultz J, Cardozo LFMF, Nakao LS, Ribeiro-Alves M, et al. Potential Trimethylamine (TMA)-Producing Bacteria in patients with chronic kidney disease undergoing hemodialysis. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04191-6
BibTeX
@article{Alvarenga2024,
author = {Alvarenga, Livia and Kemp, Julie Ann and Schultz, Júnia and Cardozo, Ludmila F M F and Nakao, Lia S and Ribeiro-Alves, Marcelo and Rosado, Alexandre and Mafra, Denise},
title = {Potential Trimethylamine (TMA)-Producing Bacteria in patients with chronic kidney disease undergoing hemodialysis},
journal = {International Urology and Nephrology},
year = {2024},
doi = {10.1007/s11255-024-04191-6}
}
EUVIMED